CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors

被引:105
作者
Ma, Yijie [1 ]
Walsh, Michael J. [1 ,2 ]
Bernhardt, Katharina [1 ]
Ashbaugh, Camille W. [1 ]
Trudeau, Stephen J. [1 ]
Ashbaugh, Isabelle Y. [1 ]
Jiang, Sizun [1 ,2 ]
Jiang, Chang [1 ]
Zhao, Bo [1 ]
Root, David E. [3 ]
Doench, John G. [3 ]
Gewurz, Benjamin E. [1 ,2 ,3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA
[2] Harvard Med Sch, Program Virol, Boston, MA 02115 USA
[3] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
关键词
NF-KAPPA-B; LATENT MEMBRANE-PROTEIN-1; ENRICHMENT ANALYSIS; SUPER-ENHANCERS; GENE-EXPRESSION; GENOME-WIDE; 3C BINDS; C-MYC; EBV; TRANSCRIPTION;
D O I
10.1016/j.chom.2017.04.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (BL) and immunosuppression-related lymphomas. These B cell malignancies arise by distinct transformation pathways and have divergent viral and host expression programs. To identify host dependency factors resulting from these EBV+, B cell-transformed cell states, we performed parallel genome-wide CRISPR/Cas9 loss-of-function screens in BL and lymphoblastoid cell lines (LCLs). These highlighted 57 BL and 87 LCL genes uniquely important for their growth and survival. LCL hits were enriched for EBV-induced genes, including viral super-enhancer targets. Our systematic approach uncovered key mechanisms by which EBV oncoproteins activate the PI3K/AKT pathway and evade tumor suppressor responses. LMP1-induced cFLIP was found to be critical for LCL defense against TNF alpha-mediated programmed cell death, whereas EBV-induced BATF/IRF4 were critical for BIM suppression and MYC induction in LCLs. Finally, EBV super-enhancer-targeted IRF2 protected LCLs against Blimp1-mediated tumor suppression. Our results identify viral transformation-driven synthetic lethal targets for therapeutic intervention.
引用
收藏
页码:580 / +
页数:19
相关论文
共 77 条
[1]   Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma [J].
Anderton, E. ;
Yee, J. ;
Smith, P. ;
Crook, T. ;
White, R. E. ;
Allday, M. J. .
ONCOGENE, 2008, 27 (04) :421-433
[2]  
[Anonymous], COLD SPRING HARB PER
[3]   An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions [J].
Arvey, Aaron ;
Tempera, Italo ;
Tsai, Kevin ;
Chen, Horng-Shen ;
Tikhmyanova, Nadezhda ;
Klichinsky, Michael ;
Leslie, Christina ;
Lieberman, Paul M. .
CELL HOST & MICROBE, 2012, 12 (02) :233-245
[4]   The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8 [J].
Banerjee, Shuvomoy ;
Lu, Jie ;
Cai, Qiliang ;
Saha, Abhik ;
Jha, Hem Chandra ;
Dzeng, Richard Kuo ;
Robertson, Erle S. .
PLOS PATHOGENS, 2013, 9 (05)
[5]   Roles of BCL6 in normal and transformed germinal center B cells [J].
Basso, Katia ;
Dalla-Favera, Riccardo .
IMMUNOLOGICAL REVIEWS, 2012, 247 :172-183
[6]   A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog [J].
Bernhardt, Katharina ;
Haar, Janina ;
Tsai, Ming-Han ;
Poirey, Remy ;
Feederle, Regina ;
Delecluse, Henri-Jacques .
PLOS PATHOGENS, 2016, 12 (01)
[7]   Role of NF-κB in cell survival and transcription of latent membrane protein 1 -: Expressing or Epstein-Barr virus latency III-infected cells [J].
Cahir-McFarland, ED ;
Carter, K ;
Rosenwald, A ;
Giltnane, JM ;
Henrickson, SE ;
Staudt, LM ;
Kieff, E .
JOURNAL OF VIROLOGY, 2004, 78 (08) :4108-4119
[8]   Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals [J].
Caldwell, RG ;
Wilson, JB ;
Anderson, SJ ;
Longnecker, R .
IMMUNITY, 1998, 9 (03) :405-411
[9]   Metabolic Reprogramming Is Required for Antibody Production That Is Suppressed in Anergic but Exaggerated in Chronically BAFF-Exposed B Cells [J].
Caro-Maldonado, Alfredo ;
Wang, Ruoning ;
Nichols, Amanda G. ;
Kuraoka, Masayuki ;
Milasta, Sandra ;
Sun, Lillian D. ;
Gavin, Amanda L. ;
Abel, E. Dale ;
Kelsoe, Garnett ;
Green, Douglas R. ;
Rathmell, Jeffrey C. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (08) :3626-3636
[10]   Latent Membrane Protein 2 (LMP2) [J].
Cen, Osman ;
Longnecker, Richard .
EPSTEIN BARR VIRUS, VOL 2: ONE HERPES VIRUS: MANY DISEASES, 2015, 391 :151-180